Fresenius Kabi Baltics - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 9,220,548 | 9,857,204 | 9,947,624 | 11,182,884 | 12,391,737 | 13,701,269 | 14,657,551 | 16,093,796 |
| Profit before tax | 387,450 | 258,487 | 126,685 | 208,703 | 211,009 | 527,008 | 673,550 | 687,385 |
| Net profit | 300,764 | 204,745 | 79,003 | 112,748 | 108,743 | 384,137 | 550,578 | 544,025 |
| Equity | 1,297,328 | 1,502,073 | 1,581,076 | 1,693,824 | 1,802,567 | 2,186,704 | 2,737,282 | 1,281,307 |
| Liabilities | 3,970,336 | 4,549,255 | 4,147,364 | 3,975,824 | 4,549,176 | 5,581,873 | 5,296,800 | 7,085,964 |
| Non-current assets | 274,214 | 302,493 | 254,320 | 186,488 | 148,105 | 107,920 | 226,087 | 303,639 |
| Current assets | 5,146,996 | 5,880,181 | 5,579,867 | 5,549,881 | 6,552,756 | 7,879,901 | 7,937,311 | 8,201,540 |
| Total assets | 5,421,210 | 6,182,674 | 5,834,187 | 5,736,369 | 6,700,861 | 7,987,821 | 8,163,398 | 8,505,179 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 835,769 | 870,155 | 1,074,821 |
| Social insurance contributions | - | - | - | - | - | 262,269 | 300,311 | 341,064 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +2.7% | +6.9% | +0.9% | +12.4% | +10.8% | +10.6% | +7.0% | +9.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.5% | 3.3% | 1.4% | 2.0% | 1.6% | 4.8% | 6.7% | 6.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.2% | 13.6% | 5.0% | 6.7% | 6.0% | 17.6% | 20.1% | 42.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.3% | 2.1% | 0.8% | 1.0% | 0.9% | 2.8% | 3.8% | 3.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 4.2% | 2.6% | 1.3% | 1.9% | 1.7% | 3.8% | 4.6% | 4.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.1 | 3.0 | 2.6 | 2.3 | 2.5 | 2.6 | 1.9 | 5.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 639,574 | 585,578 | 537,709 | 601,771 | 685,259 | 657,662 | 712,109 | 728,777 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Fresenius Kabi Baltics - Social security debts
The company had no debts to Sodra
Fresenius Kabi Baltics - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Fresenius Kabi Baltics, UAB (code 302992398) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, it generated revenue of €16.09M, up 9.8% year on year and 17.5% compared with 2023. Net profit in 2025 was €544.0K, following €550.6K in 2024 and €384.1K in 2023, while the profit margin was 3.4%. The revenue trend has been steadily upward over the past three years, even though profit was slightly below the 2024 level. At the end of 2025, total assets stood at €8.51M, equity at €1.28M, and liabilities at €7.09M. The company’s equity ratio was 15.1%, debt-to-equity was 5.53, asset turnover was 1.89x, ROA was 6.4%, and ROE was 42.5%. Productivity remained strong, with revenue per employee of €731.5K and profit per employee of €24.7K in 2025.